London — With all of the advances in the treatment of skin cancers that have been developed in the past few decades, the most important way to deal with skin cancer today is still to prevent it.
FDA Approves Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Definitions and Diagnostic Criteria of Generalized Pustular Psoriasis Require Continuity, Accuracy, Researchers Report
Comparing Devices to Assess Facial Pigmentary and Inflammatory Conditions